Sunday, April 18, 2021

Tag: NASDAQ

Emerging Growth Companies NASDAQ

CytoDyn (OTCQB: CYDY) Stuns FDA with 400% Improvement in 14 Day...

CytoDyn Inc. (OTCMKTS: CYDY) just released stunning numbers which takes the company down one of two roads.  The first road is a quick review by the FDA...

Experts claim they identified human genes that can protect against Covid-19,...

A team of scientists say they have identified the genes that can protect human cells against Covid-19. The scientists from the New York Genome Center, New York University and Icahn School of Medicine at Mount Sinai used CRISPR, a technology that allows them to alter DNA sequences, to make their discoveries.

Short-Sellers Just Won Their Bet on This Vaccine Stock, while ...

Short-sellers gained a lot of attention in recent days as they rushed to cover positions in rapidly rising stocks such as GameStop (NYSE:GME). In this case, they lost their bets on the stock's decline -- and their money. But in some cases, the shorted stock does fall. And short-sellers come out on top. That happened last week with a high-flying coronavirus vaccine stock.

New Covid strains ‘may even escape the immune response,’ says Biden...

Three highly contagious mutations of Covid have been detected in at least 33 states across the U.S., according to the Centers for Disease Control and Prevention. Researchers say these highly transmissible variants could prolong the pandemic and potentially create another surge. Projections out of the CDC even predict the U.K. variant to be the dominant variant in the U.S. by March. Gounder, an epidemiologist at NYU, told host Shepard Smith that she’s “concerned” that people will let their guards down in March and that it could potentially lead to another surge. “That’s a time when you might have some families taking spring break, so you would have the additive effect of, again, a holiday where people might be socializing, not taking all the safety measures, on top of this far more contagious variant,” warned Gounder. 

Johnson & Johnson requests emergency authorization from FDA for Covid vaccine...

Johnson & Johnson (NY:JNJ) applied for an emergency use authorization from the Food and Drug Administration for its coronavirus vaccine after releasing data last week showing it was about 66% effective in protecting against the virus.

Vaxart shares plunge over 60 % due to ineffective oral COVID...

An experimental coronavirus vaccine taken by mouth showed promising results in an early-stage clinical trial of 35 healthy adults, South San Francisco-based Vaxart (NQ: VXRT) said Wednesday. Despite the results, Vaxart’s (NQ: VXRT) stock plunged 60% in intraday trading.

Dr. Gottlieb says J&J Covid vaccine trial yields very good results....

Across all geographies, the vaccine was 85% effective in preventing severe cases of Covid-19 after four weeks, according to J&J (NYSE: JNJ). Protection improved over time, the company said, with zero participants reporting a severe case after 49 days. Additionally, J&J (NYSE: JNJ) said the vaccine provided complete protection against Covid-related hospitalizations after four weeks.

Cramer urges caution on GameStop, says there are ‘easier ways to...

Avalon GloboCare is in the process of establishing a state-of-the-art research facility, the Christian Doppler Laboratory, located on the BOKU campus in Vienna, Austria, under the scientific leadership of Professor Eva-Kathrin Ehmoser, the Head of BOKU’s Institute for Synthetic Bio architectures and Professor Uwe Sleytr, a member of the Austrian Academy of Sciences.

As GameStop mayhem continues what is next for this heavily shorted...

Short-sellers have lost about $20 billion this month, including a nearly $8 billion loss on Friday as the stock jumped 68%, according to data from S3 Partners. Following GameStop, retail investors dove into other heavily-shorted stocks like BlackBerry (NY:BB), AMC Entertainment (NY:AMC) and Bed Bath & Beyond (NQ BBBY).

The top 3 Corona Virus stocks for 2021

Avalon GloboCare is in the process of establishing a state-of-the-art research facility, the Christian Doppler Laboratory, located on the BOKU campus in Vienna, Austria, under the scientific leadership of Professor Eva-Kathrin Ehmoser, the Head of BOKU’s Institute for Synthetic Bio architectures and Professor Uwe Sleytr, a member of the Austrian Academy of Sciences. In connection with the new facility, Avalon and BOKU have signed a Memorandum of Understanding (MOU) to jointly apply for a matching research grant from the prestigious Christian Doppler Laboratory Foundation. Avalon also has research being done in MIT (Massachusetts Institute of Technology), the UNRLS (University of Natural Resources and life sciences in Australia), Weill Cornell Medicine in New York City and the Lu Daopei Medical Group in China, which has the country’s top ranked hematology and bone marrow transplant program